Ifp Advisors, Inc Castle Biosciences Inc Transaction History
Ifp Advisors, Inc
- $2.91 Billion
- Q4 2024
A detailed history of Ifp Advisors, Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 161 shares of CSTL stock, worth $4,461. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161Holding current value
$4,461% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CSTL
# of Institutions
204Shares Held
26MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$84.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$50.8 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$50.6 Million0.26% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$39.8 Million0.02% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$35 Million0.61% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $729M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...